RET Gene Mutation
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations (NCT04161391) | Turning Point Therapeutics, Inc. | 2019-12-06 |
| Continued Access to RXDX-105 (NCT03784378) | Memorial Sloan Kettering Cancer Center | 2018-12-14 |
Track RET Gene Mutation automatically
Every clearance here is in the API, with alerts when new ones post.